Skip to main content
. 2021 Nov 12;10(11):3141. doi: 10.3390/cells10113141

Figure 3.

Figure 3

Plasma lipid metabolites altered in AMD patients. Plasma levels of LysoPC (18:4) and LysoSM (d18:1) were higher in NVAMD patients compared with IAMD patients or controls Plasma levels of N-oleoylethanolamine and linoleoyl ethanolamide were higher in NVAMD patients compared to controls. Kruskal–Wallis tests were used for pairwise comparisons and p-values are shown above comparison brackets. The molecular identities of these metabolites have been confirmed at MSI level 1 or 2.